Oruka Therapeutics Inc.
ORKA | NASDAQ
$95.56
-$1.31 (-1.35%)
Nov 2, 2026, 12:50 PM ET · Market open
Fiscal Year Period Ending | FY 2025 Dec 31, 2025 | FY 2024 Dec 31, 2024 | FY 2023 Dec 31, 2023 | FY 2022 Dec 31, 2022 | FY 2021 Dec 31, 2021 | FY 2020 Dec 31, 2020 |
|---|---|---|---|---|---|---|
PE Ratio | -13.12 | -3.89 | -4.59 | -3.44 | -1.55 | -5.73 |
PEG Ratio | 0.24 | -0.31 | 0.10 | 0.07 | -0.02 | 0.07 |
PS Ratio | n/a | n/a | n/a | n/a | n/a | n/a |
PB Ratio | 2.93 | 0.85 | 7.94 | 9.83 | 7.03 | 4.87 |
P/FCF Ratio | -15.64 | -5.61 | n/a | -37.55 | -19.08 | -29.27 |
P/OCF Ratio | -15.67 | -5.63 | n/a | -37.56 | -19.12 | -29.34 |
OCF/S Ratio | n/a | n/a | n/a | n/a | n/a | n/a |
Debt / Equity Ratio | 0 | 0 | 0.01 | 0.01 | 0.01 | 0.01 |
Quick Ratio | 22.37 | 28.89 | 59.01 | 37.72 | 15.56 | 14.28 |
Current Ratio | 22.37 | 28.89 | 59.01 | 37.72 | 15.56 | 14.28 |
Asset Turnover | n/a | n/a | n/a | n/a | n/a | n/a |
Interest Coverage | n/a | -60.03 | n/a | n/a | n/a | -1.09K |
Return on Equity | -22.34% | -21.90% | -14.42% | -23.82% | -37.85% | -20.93% |
Return on Assets | -21.58% | -21.14% | -14.10% | -23.04% | -35.18% | -19.31% |
Return on Invested Capital | -25.76% | -23% | -19.56% | -23.40% | -37.52% | -20.77% |
Dividend Yield | n/a | 99.82% | n/a | n/a | n/a | n/a |
Payout Ratio | n/a | -388.15% | n/a | n/a | n/a | n/a |
FCF Payout Ratio | n/a | n/a | n/a | n/a | n/a | n/a |
Gross Profit Margin | n/a | n/a | n/a | n/a | n/a | n/a |
Net Profit Margin | n/a | n/a | n/a | n/a | n/a | n/a |
Pretax Profit Margin | n/a | n/a | n/a | n/a | n/a | n/a |
Operating Profit Margin | n/a | n/a | n/a | n/a | n/a | n/a |
FCF Margin | n/a | n/a | n/a | n/a | n/a | n/a |
EBITDA Margin | n/a | n/a | n/a | n/a | n/a | n/a |
Add to Watchlist
Select watchlists to add or remove ORKA